Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Should I Take Aspirin? (SITA): RCT of a decision aid for cancer chemoprevention.
Onwuka SR, Boyd L, Wijesuriya R, Broun K, Marker J, Shub M, McIntosh JG, Macrae F, Chondros P, Saya S, Novy K, Jenkins MA, Walter FM, Trevena L, Martinez Gutierrez J, Fishman G, Emery J. Onwuka SR, et al. Among authors: saya s. Br J Gen Pract. 2024 Mar 25:BJGP.2023.0385. doi: 10.3399/BJGP.2023.0385. Online ahead of print. Br J Gen Pract. 2024. PMID: 38527793
Neutrophil-to-lymphocyte ratio associates with nutritional parameters, intratumoral immune profiles, and clinical outcomes of pembrolizumab in head and neck squamous cell carcinoma.
Morimoto H, Tsujikawa T, Miyagawa-Hayashino A, Kimura A, Saburi S, Murakami N, Kitamoto K, Mukudai S, Nagao H, Saya S, Ogi H, Konishi E, Itoh K, Hirano S. Morimoto H, et al. Among authors: saya s. Head Neck. 2024 Feb 12. doi: 10.1002/hed.27671. Online ahead of print. Head Neck. 2024. PMID: 38344945
The clinical impact of macrophage polarity after Kasai portoenterostomy in biliary atresia.
Nagayabu K, Fumino S, Shimamura A, Sengoku Y, Higashi M, Iguchi M, Aoi S, Saya S, Hirai M, Ogi H, Miyagawa-Hayashino A, Konishi E, Itoh K, Tajiri T, Ono S. Nagayabu K, et al. Among authors: saya s. Front Pediatr. 2024 Jan 22;12:1338131. doi: 10.3389/fped.2024.1338131. eCollection 2024. Front Pediatr. 2024. PMID: 38318455 Free PMC article.
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.
Saya S, Chondros P, Abela A, Mihalopolous C, Chatterton ML, Gunn J, Chen TF, Polasek TM, Dettmann E, Brooks R, King M, Spencer L, Alphonse P, Milton S, Ramsay G, Siviour Z, Liew J, Ly P, Thoenig M, Seychell R, La Rocca F, Hesson LB, Mejias N, Sivertsen T, Galea MA, Bousman C, Emery J. Saya S, et al. Trials. 2023 May 19;24(1):342. doi: 10.1186/s13063-023-07361-6. Trials. 2023. PMID: 37208772 Free PMC article.
Designing a decision aid for cancer prevention: a qualitative study.
Milton S, Macrae F, McIntosh JG, Saya S, Alphonse P, Yogaparan T, Karnchanachari N, Novy K, Nguyen P, Lau P, Emery J. Milton S, et al. Among authors: saya s. Fam Pract. 2023 Apr 14:cmad042. doi: 10.1093/fampra/cmad042. Online ahead of print. Fam Pract. 2023. PMID: 37058423
Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants.
Dias A, Brook MN, Bancroft EK, Page EC, Chamberlain A, Saya S, Amin J, Mikropoulos C, Taylor N, Myhill K, Thomas S, Saunders E, Dadaev T, Leongamornlert D, Dyrsø Jensen T, Evans DG, Cybulski C, Liljegren A, Teo SH, Side L; IMPACT study collaborators and Steering Committee; Kote-Jarai Z, Eeles RA. Dias A, et al. Among authors: saya s. BJUI Compass. 2023 Jan 9;4(3):361-373. doi: 10.1002/bco2.156. eCollection 2023 May. BJUI Compass. 2023. PMID: 37025481 Free PMC article.
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening.
Emery JD, Jenkins MA, Saya S, Chondros P, Oberoi J, Milton S, Novy K, Habgood E, Karnchanachari N, Pirotta M, Trevena L, Bickerstaffe A, De Abreu Lourenço R, Crothers A, Ouakrim DA, Flander L, Dowty JG, Walter FM, Clark M, Doncovio S, Etemadmoghadam D, Fishman G, Macrae F, Winship I, McIntosh JG. Emery JD, et al. Among authors: saya s. Br J Gen Pract. 2023 Jul 27;73(733):e556-e565. doi: 10.3399/BJGP.2022.0480. Print 2023 Aug. Br J Gen Pract. 2023. PMID: 37012077 Free PMC article. Clinical Trial.
Determining the role of genetic risk scores in symptomatic cancer detection.
Bailey SE, Butler CA, Katsampouris E, Kessler L, Quaife SL, Saya S, Merriel SW. Bailey SE, et al. Among authors: saya s. Br J Gen Pract. 2023 Feb 23;73(728):106-107. doi: 10.3399/bjgp23X732069. Print 2023 Mar. Br J Gen Pract. 2023. PMID: 36823064 Free PMC article. No abstract available.
The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.
Saya S, Boyd L, Chondros P, McNamara M, King M, Milton S, Lourenco RA, Clark M, Fishman G, Marker J, Ostroff C, Allman R, Walter FM, Buchanan D, Winship I, McIntosh J, Macrae F, Jenkins M, Emery J. Saya S, et al. Trials. 2022 Sep 27;23(1):810. doi: 10.1186/s13063-022-06734-7. Trials. 2022. PMID: 36163034 Free PMC article.
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.
Loveday C, Garrett A, Law P, Hanks S, Poyastro-Pearson E, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Walker L; Breast and Ovarian Cancer Susceptibility Collaboration; Eccles D, Evans DG, Snape K, Hanson H, Houlston RS, Turnbull C. Loveday C, et al. Ann Oncol. 2022 Dec;33(12):1318-1327. doi: 10.1016/j.annonc.2022.09.152. Epub 2022 Sep 17. Ann Oncol. 2022. PMID: 36122798 Free article.
45 results